These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33414085)

  • 41. Gastrointestinal bleeding.
    Gralnek IM
    Endoscopy; 2014 Sep; 46(9):772-4. PubMed ID: 25133475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
    Yang Z; Wu Q; Liu Z; Wu K; Fan D
    Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton-pump inhibitors for upper-gastrointestinal bleeding.
    Rivkin K; Lyakhovetskiy A
    Am J Health Syst Pharm; 2006 Feb; 63(3):216-7. PubMed ID: 16434779
    [No Abstract]   [Full Text] [Related]  

  • 44. Proton-pump inhibitors for upper-gastrointestinal bleeding.
    Cohen H; Rebuck JA
    Am J Health Syst Pharm; 2006 Feb; 63(3):214, 216. PubMed ID: 16434778
    [No Abstract]   [Full Text] [Related]  

  • 45. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.
    Barkun AN; Cockeram AW; Plourde V; Fedorak RN
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1565-84. PubMed ID: 10594391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unintended consequences of therapy in the intensive care unit.
    Kim R; Goss CH
    JAMA Intern Med; 2014 Apr; 174(4):574-6. PubMed ID: 24534847
    [No Abstract]   [Full Text] [Related]  

  • 47. Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
    Furuta T
    Intern Med; 2009; 48(21):1847-8. PubMed ID: 19881232
    [No Abstract]   [Full Text] [Related]  

  • 48. The pharmacological therapy of non-variceal upper gastrointestinal bleeding.
    Greenspoon J; Barkun A
    Gastroenterol Clin North Am; 2010 Sep; 39(3):419-32. PubMed ID: 20951910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding.
    Barkun AN
    Drugs Today (Barc); 2003 Mar; 39 Suppl A():3-10. PubMed ID: 12712215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
    Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acid suppression in critically ill patients: what does the evidence support?
    Spirt MJ
    Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
    Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.
    Julapalli VR; Graham DY
    Dig Dis Sci; 2005 Jul; 50(7):1185-93. PubMed ID: 16047458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.
    Mohamed SA; al Karawi MA
    Hepatogastroenterology; 1996; 43(10):863-5. PubMed ID: 8884305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upper gastrointestinal bleeding in critically ill patients: proton-pump inhibitors, histamine-2 receptor antagonists or placebo? Many questions remain unanswered.
    García-Rayado G; Lanas A
    Curr Med Res Opin; 2018 Nov; 34(11):1881-1883. PubMed ID: 30095019
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding.
    Olsen KM
    Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S18-23. PubMed ID: 15905596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Risk factors of upper gastrointestinal complications in outpatients on antiplatelet therapy: description and management].
    Ducrocq G; Bigard MA; Marouene S; Delaage PH; Fabry C; Barthelemy P; Steg PG;
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):245-51. PubMed ID: 22579299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.